Best Guam Grants for Nonprofits

The Healthy Tomorrows Partnership for Children Program (HTPCP) aims to enhance access to essential preventive clinical and public health services for children through community-driven initiatives. Funded by the US HHS: Health Resources & Services Administration (HRSA), this program focuses on empowering local communities to implement effective strategies that improve children's health outcomes and promote overall well-being. Projects funded under this initiative will play a vital role in ensuring healthier futures for children.

The Home Visiting Research, Improvement, Sustainability and Evaluation Center (HV-RISE) aims to enhance home visiting services for families. By leveraging research, HV-RISE supports programs in testing and implementing effective practices, thereby improving outcomes. This initiative seeks to identify and expand successful strategies, ensuring that families receive the best support possible through evidence-based home visiting services.

The CDC's initiative, 'Holistic and Evidence-Informed Wellness for STI Prevention', addresses the significant public health burden of STIs in the U.S. by promoting a comprehensive approach that emphasizes healthy choices and relationships. By supporting a coalition of sexual health experts, the program aims to enhance STI prevention through strategic resource allocation and the dissemination of high-quality, evidence-based materials, targeting priority groups most affected by STIs. This holistic strategy seeks to reduce STI morbidity and improve overall sexual health.

The Maternal, Infant, and Early Childhood Home Visiting Program (MIECHV) aims to enhance maternal and child health, promote early childhood development, and support family well-being. By providing voluntary, evidence-based home visiting services to pregnant women and families with young children, the program addresses critical needs in communities. Funded by the US HHS: Health Resources & Services Administration (HRSA), MIECHV empowers families through tailored support and resources, fostering healthier outcomes for mothers and their children.

The FY26 Defense Established Program to Stimulate Competitive Research (DEPSCoR) Capacity Building opportunity aims to enhance the capabilities of university researchers in eligible states. Managed by the DoD, this initiative focuses on increasing the number of researchers capable of conducting relevant science and engineering research. The program also seeks to strengthen institutions of higher education and improve their competitiveness for federal research funding, ultimately fostering long-term growth in financial assistance for scientific research.

The FY26 Defense Established Program to Stimulate Competitive Research (DEPSCoR) aims to enhance research capabilities in eligible states by increasing the number of university researchers and institutions conducting relevant science and engineering research. Sponsored by the Department of Defense, this program will fund multiyear awards to promote research aligned with national security needs. Applications require a multi-stage submission process, emphasizing early registration and timely proposal submissions.

The ROSES 2025 program is focused on enhancing the scientific and technical readiness of key Decadal Survey investigations in heliophysics, specifically 'Links' and 'Solar Polar'. It aims to support research that aligns with the 2024 Heliophysics Decadal Survey's goals by identifying completable science objectives. Proposals should include innovative mission architecture and science objectives, while leveraging existing capabilities of heliophysics missions, without soliciting specifications for observations or instrumentation.

The OJJDP FY 2026 Juvenile Justice System Enhancements program aims to bolster the effectiveness of juvenile justice systems across the nation. By targeting high-cost drivers of crime and enhancing youth outcomes, this initiative encourages states and localities to develop strategic solutions. Applicants are invited to identify challenges within their systems and prioritize resource allocation for measurable improvements, ultimately aiming to prevent crime and improve operations within the juvenile justice framework.

The Organizational Change in the Professional Formation of Engineers (ENGINEER:OC) initiative promotes innovative research and activities aimed at transforming engineering education and workforce development. Supported by the National Science Foundation (NSF), it seeks to enhance access to quality engineering programs across diverse institutions. Projects may involve implementing new curricular innovations or adapting existing models to different contexts, ultimately advancing the professional formation of engineers and fostering inclusive educational pathways.

The OJJDP FY 2026 Family Treatment Court Program aims to support state and local courts, as well as Tribal governments, in establishing or enhancing family treatment courts. These courts are designed to provide substance use treatment and other supportive services for parents involved with the child welfare system due to issues like child abuse or neglect. By focusing on intensive judicial monitoring and interventions, the program seeks to improve outcomes for children, parents, and families affected by substance use disorders.

The OJJDP FY 2026 Expanding Youth Access to Community-Based Treatment program aims to enhance support for youth facing substance use and mental health challenges. This funding opportunity focuses on community-based treatment initiatives that cater to youths with substance use disorders (SUD) and co-occurring mental health conditions. By fostering cross-system strategies, the program seeks to improve outcomes for at-risk youth and reduce recidivism through better access to necessary treatment services.

The BJA FY 2026 Residential Substance Abuse Treatment for State Prisoners Formula Grants Program aims to enhance the capacity of state, local, and tribal governments in providing residential substance use disorder treatment for incarcerated individuals. This funding opportunity supports evidence-based treatment, aids in reintegration into society, and promotes continuity of care through community-based recovery services, ultimately improving outcomes for those with substance use and co-occurring mental health disorders.

The Professional Formation of Engineers (PFE) initiative aims to enhance the engineering workforce through integrated research and education. It focuses on developing ethical engineers who can adapt to a changing technical landscape. PFE supports diverse training contexts, including formal education, internships, and community experiences, ensuring clear pathways into the profession. This initiative fosters collaboration among engineers, technical workers, and communities, enhancing the skills needed for global competition and technological advancement.

The OJJDP FY 2026 Internet Crimes Against Children On-Line Child Protection System (ICACCOPS) funding opportunity aims to enhance and maintain critical investigative tools for child exploitation cases. ICACCOPS provides a robust IT infrastructure to support data services, network security, and management tools for law enforcement. This initiative strengthens the efforts of the national network of ICAC Task Forces, which are dedicated to combating technology-facilitated child sexual exploitation across the United States.

The NIJ FY 2026 Research and Evaluation on School Safety funding opportunity aims to support essential research and evaluations focused on enhancing K-12 safety. Key areas of interest include anonymous reporting systems for threats of school violence and the establishment of threat assessment teams. Applicants are encouraged to collaborate with educators and communities to develop effective solutions and assess the impact of various safety initiatives, thereby contributing valuable insights to school safety practices.

The NIJ FY 2026 Evaluation of the Effectiveness of the Bureau of Justice Assistance (BJA) Byrne State Crisis Intervention Program (SCIP) aims to fund research assessing the effectiveness of crisis intervention initiatives. This opportunity supports evaluations across various program areas, including mental health courts and ERPO programs. Applicants must propose a two-phased strategy: Evaluability Assessments followed by a comprehensive evaluation of the SCIP's effectiveness, ensuring applications are responsive to funding requirements.

The Maximizing Investigators' Research Award (MIRA) program, established by NIGMS, aims to enhance research funding efficiency by providing stable financial support to investigators. This allows for greater scientific flexibility and encourages innovative studies. MIRA is pivotal for distributing funding among promising researchers, fostering groundbreaking research. The program invites applications from eligible NIGMS-funded and NIH-defined New Investigators, as well as current MIRA grantees seeking renewal, ensuring a broad and inclusive approach to advancing science.

The NIJ FY 2026 Crime and Justice Research funding opportunity invites applications for innovative research aimed at enhancing the effectiveness of the adult criminal justice system. It comprises two main categories: one focuses on new programs and strategies to improve workforce readiness, while the other assesses the impact of the COPS De-escalation Training Program. This initiative seeks to foster safety and operational improvements within law enforcement.

The NIH Science Education Partnership Award (SEPA) fosters innovative educational initiatives aimed at pre-college students, promoting their interest in STEM fields, especially in biomedical and behavioral sciences. This program supports both classroom projects and informal science education activities, such as after-school programs and library events. Emphasizing the development of quantitative and computational skills, SEPA seeks to inspire the next generation of scientists and thinkers through engaging educational experiences.

This funding opportunity aims to support innovative research projects targeting previously undruggable classes of proteins associated with challenging human diseases. By encouraging early-stage exploratory projects, it seeks to foster the development of novel methods and agents that can selectively modulate these hard-to-target proteins, ultimately advancing therapeutic strategies and improving patient outcomes.

What is Sea Grant?

Founded in 1968, the University of Hawaiʻi Sea Grant College Program (Hawaiʻi Sea Grant) is part of a national network of 34 programs that engage in the better understanding, conservation, and use of coastal ecosystems. Hawaiʻi Sea Grant works in partnership with the University of Hawaiʻi’s prestigious School of Ocean and Earth Science and Technology and the National Oceanic and Atmospheric Administration (NOAA) to identify Hawaiʻi’s key environmental management issues and guide cutting-edge scientific research to address these challenges.

Pacific Islands Coastal Health Fellowship Program (PICH)

The Pacific Islands Coastal Health Fellowship is a place-based program for recent graduates from the Pacific Islands who want to return home and gain meaningful, hands-on experience in environmental and community work. Fellows will be placed with organizations in Hawaiʻi, American Samoa, the Republic of the Marshall Islands, the Federated States of Micronesia, Palau, the Commonwealth of the Northern Mariana Islands, and/or Guam. Placement is dependent on fit between applicant and host organization.

Coordinated by the Hawai‘i Sea Grant Center for Pacific Ocean and Island Health and the Pacific Islands Ocean Observing Systems (PacIOOS), the fellowship places early-career professionals full-time within local government agencies or community organizations working on projects related to fisheries and coastal health. Fellows will work in partnership with participating government agencies or community-serving institutions to work on priorities identified by those agencies and their communities. Focus areas include fisheries, ciguatera, water quality, marine debris, and human health, reflecting the everyday land–sea issues island communities face.

Fellows can expect to gain skills in research, management, outreach, and education. They will receive professional training and support throughout their fellowship period. This fellowship should equip recent graduates to transition into graduate school or into a meaningful career at the conclusion of the year. We hope they will build lasting relationships with host organizations and mentors that will support long-term collaborations and project support.

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Mucopolysaccharidosis Type VII (MPS VII) Health Equity Fund

Help with healthcare costs for mucopolysaccharidosis type VII (health equity)

This TotalAssist Health Equity Fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Health Equity Funds offer help to eligible patients living in areas identified as having increased social and financial needs, as well as higher rates of chronic conditions. Eligibility is determined in part by home address zip code.

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

The National Cancer Institute (NCI) plans to issue a Notice of Funding Opportunity (NOFO) for the Paul Calabresi Career Development Award in Clinical Oncology (K12). This program aims to enhance training for clinician-scientists in cancer research, fostering their career development and collaboration with basic research scientists. It mandates diverse oncology specialties in faculty, individualized career development plans, and mentorship, supporting Scholars for up to three years to promote their research initiatives in clinical trials.

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Mucopolysaccharidosis Type VII (MPS VII) Fund

Help with healthcare costs for mucopolysaccharidosis type VII

This TotalAssist Health Equity Fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

The Western SARE Graduate Student Research and Education Grant Program supports innovative research and educational outreach in sustainable agriculture. Funded by the USDA, it aims to enhance environmental quality, improve profitability for producers, and uplift rural communities. Projects must involve both research and education components, with proposals authored by graduate students collaborating with their advisors. This initiative fosters communication of results to agricultural professionals, ensuring practical applications for sustainable practices in the Western U.S.

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Mucopolysaccharidosis Type III (MPS III) Fund

Help with healthcare costs for mucopolysaccharidosis type III

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Hemophilia Health Equity Fund

Help with healthcare costs for hemophilia (health equity fund)

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Health Equity Funds offer help to eligible patients living in areas identified as having increased social and financial needs, as well as higher rates of chronic conditions. Eligibility is determined in part by home address zip code. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant.